ACE2 and COVID-19: Substantial statistical heterogeneity between studies was observed within each virus type, except for non-ACE2-associated viruses (I2 = 95.4%, 89.6%, 0% in critically ill for COVID-19, ACE2-associated, and non-ACE2-associated, respectively).